AKP-11 is under clinical development by Akaal Pharma and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I drugs for Autoimmune Disorders have a 73% phase transition ...
Autoimmune vesiculobullous skin diseases are a common occurrence in dermatology practice and do have gender differences. While most dermal antigens and autoantibodies in these diseases have been ...
DIF of perilesional skin reveals linear deposition of IgG at the dermoepidermal junction. Indirect immunofluorescence of a patient's serum may reveal the presence of circulating anti-basement ...
If you develop autoimmune progesterone dermatitis, you may experience physical symptoms similar to an allergic reaction. Related stories "It can present with a variety of skin manifestations ...